Michael J. Rosen, MD, MSCI, focuses his career on the clinical care of children with inflammatory bowel disease (IBD), and to research aimed at better understanding the causes of chronic inflammation in childhood IBD. Studies from Dr. Rosen’s laboratory have elucidated the role of the type 2 (Th2) immune responses in regulating the intestinal inflammation and predicting response to therapy in pediatric ulcerative colitis. Dr. Rosen also leads an ongoing multi-center study to identify determinants of response to anti-TNF therapy in children hospitalized with acute severe ulcerative colitis.
Dr. Rosen's research has been funded by the National Institutes of Health, the Crohn's & Colitis Foundation, the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN), and the American College of Gastroenterology. Dr. Rosen serves on the editorial board of the journal Inflammatory Bowel Diseases. He is co-chair of the the Pediatric Affairs Committee for the Crohn's and Colitis Foundation and serves on its National Scientific Advisory Committee. His a past recipient of the NASPGHAN Fellow to Faculty Transition Award in IBD and the George Ferry Young Investigator Award.